Fresenius Kabi invests in Indonesian drugmaker
Fresenius Kabi AG, a German pharmaceutical company, announced today that it has agreed to buy a 51% stake in Indonesian drug maker PT Ethica Industri Farmasi from PT Soho Global Healthcare.
The deal could be worth as much as US$200 million. This makes Fresenius Kabi the latest foreign company to invest in this growing health-care market.
The transaction is expected to be completed by the third quarter of this year.
Fresenius inks deal for 51% stake in Indonesian drugmaker (FiercePharma)
Germany’s Fresenius Kabi Bets on Booming Indonesian Drug Market (Wall Street Journal)
Don't miss your daily pharmaphorum news.
SUBSCRIBE free here.